Vegfxta 400mg Injection
Marketer
Fresenius Kabi India Pvt Ltd
Salt Composition
Bevacizumab (400mg)
Overview Vegfxta 400mg Injection
OncoVasc 400mg Injection, an anti-neoplastic agent, treats various cancers including colorectal, non-small cell lung, renal, brain, ovarian, and cervical cancers. Its mechanism involves angiogenesis inhibition, thereby hindering tumor growth. Administered intravenously via infusion or port, OncoVasc 400mg is a frontline treatment, typically combined with other cancer therapies. Dosage and treatment length are physician-determined, with monitoring for infusion reactions like hypertension and respiratory distress. Continued use depends on disease control and manageable side effects, as decided by your oncologist. Regular blood pressure checks and urine protein level monitoring may be advised. Common side effects include rectal hemorrhage, altered taste perception, and cephalalgia. Pre-surgical disclosure to your surgeon is crucial due to potential impaired wound healing. Increased bleeding risk necessitates immediate medical attention for any unusual bleeding. Disclose pregnancy, pregnancy planning, or breastfeeding to your physician. Inform your healthcare provider of all other medications you're taking due to potential drug interactions.
Uses of Vegfxta 400mg Injection
Colorectal cancer, ovarian neoplasm, cervical carcinoma, renal cell carcinoma, brain cancer, and non-small cell lung carcinoma.
Major Benefits of Vegfxta 400mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Vegfxta 400mg Injection:
- Exfoliative dermatitis
- High blood pressure
- Nosebleeds
- Protein in urine
- Decreased appetite
- Electrolyte imbalance
- Peripheral sensory neuropathy
- Breathlessness
- Thromboembolism
- Wound healing complications
- Ovarian failure
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Mucosal inflammation
- Abscess
- Cellulitis
- Hypersensitivity
- Rectovaginal fistula
How to use Vegfxta 400mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Vegfxta 400mg Injection works:
Inhibiting vascular endothelial growth factor (VEGF), the anti-angiogenic injection Vegfxta 400mg prevents the development of new blood vessels supplying tumors with oxygen and essential nutrients.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Vegfxta 400mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Vegfxta 400mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Vegfxta 400mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administration of Vegfxta 400mg Injection may induce adverse reactions that could compromise driving ability. Reports indicate drowsiness and syncope are potential side effects of Vegfxta 400mg Injection, potentially affecting safe driving.
KidneySAFE IF PRESCRIBED
The use of Vegfxta 400mg Injection in patients with kidney disease appears to pose minimal risk. Current evidence indicates that dose modification may not be necessary for this patient population. However, medical advice is recommended.
LiverSAFE IF PRESCRIBED
The use of Vegfxta 400mg Injection in individuals with hepatic impairment is likely safe. Existing evidence indicates that dose modification for Vegfxta 400mg Injection may be unnecessary in such cases. However, physician consultation is recommended.
What if you forget to take Vegfxta 400mg Injection :
Forgetting a dose of Vegfxta 400mg Injection? Seek your physician's advice.
Facts to Know About Vegfxta 400mg Injection
| Label | Value |
|---|---|
| Chemical Type | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Active Class | VEGF-blocking agent |
3,018 People bought this recently